Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

A comparison of clinical and microbiological efficacy of antibiotic regimens against Acinetobacter baumannii.

Ackerman BH, Haith LR Jr, Patton ML, Guilday RE, Reigart CL, Stair-Buchmann M.

J Burn Care Res. 2013 Jul-Aug;34(4):403-12. doi: 10.1097/BCR.0b013e318270003a.

PMID:
23237825
2.
4.

Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections.

Lee YT, Tsao SM, Hsueh PR.

Eur J Clin Microbiol Infect Dis. 2013 Sep;32(9):1211-20. doi: 10.1007/s10096-013-1870-4. Epub 2013 Apr 5. Erratum in: Eur J Clin Microbiol Infect Dis. 2014 Jun;33(6):1063.

PMID:
23553594
5.

Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia.

Choi JY, Kim CO, Park YS, Yoon HJ, Shin SY, Kim YK, Kim MS, Kim YA, Song YG, Yong D, Lee K, Kim JM.

Yonsei Med J. 2006 Feb 28;47(1):63-9.

6.

Colistin-tigecycline versus colistin-imipenem-cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study.

Chaari A, Pham T, Mnif B, Chtara K, Medhioub F, Baccouche N, Bahloul M, Hammami A, Bouaziz M.

Intensive Care Med. 2015 Nov;41(11):2018-9. doi: 10.1007/s00134-015-4010-z. Epub 2015 Aug 12. No abstract available.

PMID:
26264246
7.

In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.

Housman ST, Hagihara M, Nicolau DP, Kuti JL.

J Antimicrob Chemother. 2013 Oct;68(10):2296-304. doi: 10.1093/jac/dkt197. Epub 2013 May 24.

PMID:
23710070
8.

[Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].

Sayin Kutlu S, Saçar S, Süzer T, Cevahir N, Okke D, Dirgen Caylak S, Turgut H.

Mikrobiyol Bul. 2008 Apr;42(2):353-8. Turkish.

PMID:
18697435
9.
10.

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.

Wood GC, Hanes SD, Croce MA, Fabian TC, Boucher BA.

Clin Infect Dis. 2002 Jun 1;34(11):1425-30. Epub 2002 Apr 30.

PMID:
12015687
12.

Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii.

Pachón-Ibáñez ME, Docobo-Pérez F, López-Rojas R, Domínguez-Herrera J, Jiménez-Mejias ME, García-Curiel A, Pichardo C, Jiménez L, Pachón J.

Antimicrob Agents Chemother. 2010 Mar;54(3):1165-72. doi: 10.1128/AAC.00367-09. Epub 2010 Jan 4.

13.

Nontraditional dosing of ampicillin-sulbactam for multidrug-resistant Acinetobacter baumannii meningitis.

Cawley MJ, Suh C, Lee S, Ackerman BH.

Pharmacotherapy. 2002 Apr;22(4):527-32.

PMID:
11939689
14.

Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii.

Corbella X, Ariza J, Ardanuy C, Vuelta M, Tubau F, Sora M, Pujol M, Gudiol F.

J Antimicrob Chemother. 1998 Dec;42(6):793-802.

PMID:
10052904
15.

Treatment of pan-drug resistant Acinetobacter baumannii.

Lee CM, Lim HK, Liu CP, Tseng HK.

Scand J Infect Dis. 2005;37(3):195-9.

PMID:
15849052
16.

Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis.

Chu H, Zhao L, Wang M, Liu Y, Gui T, Zhang J.

Braz J Infect Dis. 2013 Jul-Aug;17(4):389-94. doi: 10.1016/j.bjid.2012.10.029. Epub 2013 Apr 19. Review.

17.

[Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].

Cıkman A, Ceylan MR, Parlak M, Karahocagil MK, Berktaş M.

Mikrobiyol Bul. 2013 Jan;47(1):147-51. Turkish.

18.

Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.

Hiraki Y, Yoshida M, Masuda Y, Inoue D, Tsuji Y, Kamimura H, Karube Y, Takaki K, Kawano F.

Int J Infect Dis. 2013 Dec;17(12):e1234-6. doi: 10.1016/j.ijid.2013.05.002. Epub 2013 Jun 21.

19.

Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.

Khawcharoenporn T, Pruetpongpun N, Tiamsak P, Rutchanawech S, Mundy LM, Apisarnthanarak A.

Int J Antimicrob Agents. 2014 Apr;43(4):378-82. doi: 10.1016/j.ijantimicag.2014.01.016. Epub 2014 Feb 14.

PMID:
24613422
20.

Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome.

Kuo LC, Lai CC, Liao CH, Hsu CK, Chang YL, Chang CY, Hsueh PR.

Clin Microbiol Infect. 2007 Feb;13(2):196-8.

Supplemental Content

Support Center